Rapid Therapeutic Science Laboratories, Inc. Increase (Decrease) in Derivative Liabilities
Rapid Therapeutic Science Laboratories, Inc. reported Increase (Decrease) in Derivative Liabilities of $44.95 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2020-08-13
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in derivative liabilities for the quarter ending 2020-06-30 was $44.95K.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in derivative liabilities for the quarter ending 2019-06-30 was $0.00.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in derivative liabilities for fiscal 2020 was $32.00K.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in derivative liabilities for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|
| 2020-06-30 | $44.95K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $32.00K 10-K · filed 2020-06-29 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $0.00 10-K · filed 2020-06-29 |